Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,202 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05572216Recruiting
Robot-assisted kidney tumor surgery with 3D imaging guidance
This study compares a robot-assisted kidney-sparing surgery guided by 3D images. It aims to improve how precisely surgeons remove a complex kidney tumor while protecting kidney function.
GrenobleAges 18 years+ - NCT06269211RecruitingPhase 2
Immunotherapy before surgery for EGFR-mutated lung cancer
This trial tests whether giving an immunotherapy drug (toripalimab) before surgery can help people with a specific type of lung cancer (EGFR-mutated, PD-L1 positive) that can be removed. The goal is to see if it improves treatment results compared to surgery alone.
Guangzhou, GuangdongAges 18 years+ - NCT06446778Recruiting
Pipeline device for brain aneurysms
This trial tests a treatment called Pipeline Embolization (a thin tube placed in the artery) to fix brain aneurysms that haven't ruptured. It might help stop the aneurysm from growing or bursting.
Guangzhou, GuangdongAges 22–75 - NCT06693791RecruitingPhase 2
Romiplostim for platelet recovery after cord blood transplant
This trial tests a drug called Romiplostim N01 to help platelet levels recover faster in people with blood cancers who have had a cord blood transplant. It may reduce the need for platelet transfusions and lower bleeding risk.
Hefei, AnhuiAges 18 years+ - NCT06674096RecruitingPhase 2
Two chemotherapy sequences for elderly double expressor DLBCL
This trial tests a new sequence of two chemotherapy regimens (RLC followed by CR-CHOP) for elderly patients with a fast-growing DLBCL called double expressor lymphoma. The goal is to see if this approach is safe and effective for people who may not tolerate standard treatments.
Hangzhou, ZhejiangAges 65 years+ - NCT06523426Recruiting
Outpatient spine surgery for adults over 75
This trial tests a minimally invasive spine surgery (endoscopic decompression) done as an outpatient procedure in people 75 and older. It aims to see if this approach is safe and effective for treating a single-level lumbar spine problem.
BordeauxAges 75 years+ - NCT06693063Recruiting
Follow-up after chest pain in emergency
This study looks at whether seeing your regular doctor after a hospital visit for chest pain can help prevent future emergency visits. If you had chest pain and went to the Emile Roux emergency room, you may be able to join.
Le Puy-en-VelayAges 18 years+ - NCT06692855Recruiting
Frailty score's role in predicting outcomes for cardiogenic shock
This study looks at whether a simple frailty score (measuring how well someone can function) can help predict recovery for people hospitalized with cardiogenic shock, a condition where the heart suddenly can't pump enough blood.
StrasbourgAges 18 years+ - NCT07630467Recruiting
Video Laryngoscopy for Emergency Airway Management
This pilot study tests a new camera-assisted tool to help paramedics insert breathing tubes in emergencies. Researchers want to see if this device makes the procedure safer and more successful when done outside the hospital.
ValenciennesAges 18 years+ - NCT07630506RecruitingPhase 2
Folinic Acid for Autism in Children Ages 3–10
This study tests whether folinic acid (a type of B vitamin) can help improve symptoms of autism in children. Researchers want to see if this supplement, combined with your child's current treatments, might make a difference.
Singapore, SingaporeAges 3–10 - NCT07629817RecruitingPhase 3
Surgery vs. Chemoradiation for Esophageal Cancer
This trial compares surgery versus a strong combination of chemotherapy and radiation for people with esophageal squamous cell carcinoma that has been treated first with immunotherapy. It aims to find which approach leads to better outcomes after the initial immunotherapy and chemotherapy.
Zhengzhou, HenanAges 18–75 - NCT03193567RecruitingPhase 1
Cell therapy study for advanced lung cancer after treatment failure
This Phase 1 trial tests a powerful “killing cell” therapy for people with advanced non-small cell lung cancer whose cancer did not respond to standard chemotherapy and targeted drugs. The goal is to see if this new treatment is safe and may work after other treatments have failed.
ShanghaiAges 18–70 - NCT03024671Recruiting
Skin patch testing for how cosmetics affect skin
This trial studies how certain cosmetics affect skin by using a patch test on your back. You might help researchers understand which products are less likely to cause skin reactions.
BernAges 18 years+ - NCT05217966Recruiting
Radiation before possible breast surgery for early ER-positive cancer
This study gives radiation to the breast before surgery to see if some people can safely delay or even skip surgery. It targets women with a small, node-negative, ER-positive breast cancer with low genetic risk.
Montreal, QuebecAges 50 years+ - NCT04973293Recruiting
Pre-surgery immunotherapy plus chemo and blood-vessel medicine for lung cancer
This study tests whether giving sintilimab (an immune therapy) combined with bevacizumab (a blood-vessel–targeting medicine) plus chemotherapy before surgery can improve outcomes for resectable lung cancer. It’s meant for people with specific lung cancer types and good health for surgery, and it avoids certain cancer types and immune-related risks.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT05040542Recruiting
Brain scans of social emotions in infants
This study uses brain testing (including MRI scanning) to better understand how young children’s brains support social emotions and communication. It may help researchers learn what brain patterns look like in typical early development.
Xiamen, FujianAges Up to 6 years - NCT05436054RecruitingPhase 4
Plenvu vs Picoprep bowel prep for colonoscopy
This study compares two bowel-cleansing products (Plenvu and Picoprep) to see which works better and is easier to tolerate before a colonoscopy. It may help patients by improving the chance of a clear exam and reducing unpleasant side effects.
Aalborg, North JutlandAges 18 years+ - NCT05979818RecruitingPhase 1
Propranolol plus immunotherapy and chemo for advanced lung cancer
This trial tests adding a beta-blocker (propranolol) to a combination of immunotherapy (sintilimab) and standard chemotherapy for people with advanced non-small cell lung cancer that hasn't been treated before. The goal is to see if this new triple treatment helps shrink tumors better than chemo-immunotherapy alone.
Changsha, HunanAges 18–75 - NCT07635134Recruiting
Testing a new method to diagnose primary aldosteronism
This study is developing a better blood test to diagnose primary aldosteronism, a condition where the adrenal glands produce too much of a hormone called aldosterone, causing high blood pressure. Researchers are comparing results from healthy volunteers and patients suspected of having this condition to find the right cutoff numbers for the new test.
Beijing, Beijing MunicipalityAges 18–70 - NCT07635836Recruiting
Two surgical approaches for upper stomach cancer
This trial compares two different surgical techniques for removing upper stomach cancer. The study tests which reconstruction method—double-tract or tubular—leads to better outcomes and quality of life after surgery.
Jinan, ShandongAges 18–75 - NCT07632131Recruiting
Storytelling therapy to prevent PTSD after heart surgery
This study tests whether a special therapy called narrative exposure—where you talk through your surgery experience with a trained counselor—can help prevent PTSD (post-traumatic stress) in people recovering from heart surgery in the ICU. The goal is to help you process what happened so you feel less distressed afterward.
Fuzhou, FujianAges 18 years+ - NCT07635394Recruiting
Pregabalin for Irritable Bowel Syndrome Relief
This study tests whether pregabalin, a nerve-pain medication, can help reduce irritable bowel syndrome (IBS) symptoms like abdominal pain and irregular bowel habits. Researchers want to see if it's safe and effective for people with mild-to-moderate IBS.
Beijing, Beijing MunicipalityAges 18–70 - NCT07629947Recruiting
Bone marrow or blood cells for severe aplastic anemia transplant
This trial studies using a donor's blood stem cells (from bone marrow or blood) for a transplant in people with severe aplastic anemia, a condition where the bone marrow stops making enough blood cells. The goal is to see if using a mix of both types of cells is better than just blood cells alone.
Beijing, Beijing MunicipalityAges 18–40 - NCT07630337Recruiting
Cryotherapy to reduce pain medication after knee replacement
This study tests whether applying cold therapy (cryotherapy) after knee replacement surgery helps patients need fewer opioid pain medications than standard care alone. If cryotherapy works, it could help you manage pain more safely after surgery.
Buenos Aires, Buenos AiresAges 18 years+
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,202 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.